Skip to Content

COVID-19 Vaccination Information

ss

Vaccination is vital to the country’s efforts to bring the pandemic to an end. The Texas Department of State Health Services (DSHS) has established mass vaccination centers called Hubs to provide the public with vaccinations as quickly as possible. DSHS has also approved other vaccine providers, including Texas State University, to assist by vaccinating populations they serve. Texas State has developed a comprehensive plan to administer vaccinations to faculty, staff and students if and when vaccine becomes available. Vaccine will be provided at no cost to individuals. The information on this webpage will be updated regularly as vaccine doses become available and vaccination events are scheduled. To view Dr. Carranco's Vaccination Plan video, please visit the video section fo this webpage. (Last updated 2/24/2021)

Texas Vaccination Hubs

The Texas Department of State Health Services has established Hub vaccination sites for mass vaccination of those who meet the priority group eligibility criteria and without regard to county of residence. Vaccine allocations will be prioritized to the Hubs. Due to the uncertainty of when Texas State might receive vaccine, faculty, staff and students eligible for vaccinations are encouraged to get vaccinated through a Hub or other provider that has vaccine. For more information on Hub vaccination sites and how to obtain a vaccination, click Texas COVID-19 Vaccination Information.

Vaccine Registration Portals

Some vaccine providers are establishing vaccine registration portals to allow persons eligible for vaccination to pre-register for the vaccine. In most cases, persons who have pre-registered will receive a notification when vaccine is available for them. Pre-registration is not a guarantee that a person will receive a vaccination. Below is a list of some of the vaccine registration portals in the Central Texas area:

Texas State Vaccination Plan

A COVID-19 Mass Vaccination Planning Work Group was established in October 2020 at the direction of President Trauth. The work group was charged with developing plans for mass vaccination when the COVID-19 vaccine became available. A mass vaccination plan has been developed. The process for vaccinations includes:

  • Current faculty, staff and students will be eligible for vaccinations provided during on-campus vaccination events
  • Vaccinations will be administered according to Vaccine Priority Groups established by DSHS
  • Priority group members will be contacted by university e-mail when vaccine is available and provided with a vaccination registration link 
  • Priority group members will be assigned a vaccination date and time for the first and second doses of vaccine
  • Persons who miss their scheduled vaccination will have an opportunity to register for vaccination during the next scheduled vaccination event
  • Vaccinations will be provided on Tuesdays or Fridays at the San Marcos Campus and on specific to-be-determined dates at the Round Rock Campus
  • Vaccinations will be administered in the LBJ Student Center Grand Ballroom and the Avery Building

Priority Groups Eligible for Vaccination

  • Phase 1A:  healthcare, emergency responders, long term care residents and staff, last responders, pharmacy
  • Phase 1B:  persons 65 and older, persons 16 and older with chronic medical conditions including pregnancy

Vaccination Allocations

Texas State University is awaiting its first allocation of vaccine from DSHS. All Bobcats currently eligible to receive COVID-19 vaccine are encouraged to get vaccinated through a Hub or other provider.

Date Vaccine Doses Total Doses Priority Groups to be Vaccinated
  None      
         
         

Scheduled Vaccination Events

Round Rock Campus

  • Avery Building—date to-be-determined

San Marcos Campus

  • LBJ Student Center Grand Ballroom—date to-be-determined

Approved Vaccines

  • Pfizer-BioNTech
  • Moderna

Currently approved COVID-19 vaccines in the United States include Pfizer-BioNTech and Moderna. Both vaccines are messenger RNA (mRNA) vaccines which introduce a genetic code into cells for producing the spike protein that exists on the outer surface of the coronavirus. The genetic code does not enter the cell’s nucleus where a person’s DNA is located. The cells make the spike protein which then triggers an immune response to destroy the virus. For more information about mRNA vaccines, check Understanding mRNA COVID-19 Vaccines | CDC.

The Pfizer-BioNTech and Moderna vaccines are 95% and 94% effective, respectively, at preventing COVID-19 illness based on clinical data submitted to the FDA. Most side effects were mild to moderate including pain, swelling and redness at the injection site, fatigue, headache, chills and fever. A small number of those vaccinated experienced more significant side effects. Rare severe allergic reactions were also reported. For more information about the vaccines, check Pfizer-BioNTech COVID-19 Vaccine | CDC and information about the Moderna COVID-19 Vaccine | CDC.

  • Vaccine FAQs

    • When Texas State is allocated vaccine, an e-mail will be sent to current faculty, staff and students who meet the DSHS priority group criteria. The e-mail will include a vaccination registration link to reserve your date and time for vaccination.

    • Yes, vaccines authorized or approved for use in the United States must adhere to strict standards for safety. Vaccine manufacturers must provide the Food and Drug Administration (FDA) with information on the vaccine’s effectiveness and safety, typically based on results from thousands of patients participating in clinical trials. The FDA reviews the information and issues an Emergency Use Authorization (EUA) for a vaccine if it has demonstrated its effectiveness and safety. Then, the CDC’s Advisory Committee on Immunization Practices (ACIP), which includes medical and public health experts, reviews the clinical data on the vaccine’s effectiveness and safety before determining whether to recommend the use of the vaccine. The ACIP has recommended the use of the Pfizer-BioNTech and Moderna vaccines. The FDA and CDC continue to monitor safety and long-term side effects.

    • Yes, the CDC recommends that persons who have been previously infected with COVID-19 get vaccinated. It is unclear how long the natural immunity that develops after infection lasts. Because it is rare that a person infected with COVID-19 will be reinfected within 90 days due to their natural immunity, they can wait up to 90 days before getting vaccinated.

    • Most of the COVID-19 vaccines will require two doses to produce the optimum immune response and protection. Early data indicates that one dose of vaccine does not produce the optimum immune response and it is unclear how long immunity will last.

    • Yes, even after completing the COVID-19 vaccine series, the use of face masks and social distancing must be continued. While the vaccination may prevent you from developing serious illness, it is unclear whether it prevents you from spreading the infection. The CDC and other medical experts will continue to assess the effect of vaccination on illness and spread.

    • No, COVID-19 vaccination is not required to work at Texas State at this time. Vaccination is strongly recommended to protect yourself from developing serious illness due to COVID-19. It may also help decrease the spread of the infection to others. Studies continue to assess all the potential benefits of vaccination.

    • No, COVID-19 vaccination is not required to attend classes at Texas State at this time. Vaccination is strongly recommended to protect yourself from developing serious illness due to COVID-19. It may also help decrease the spread of infection to others. Studies continue to assess all the potential benefits of vaccination.

    • For other questions about the COVID-19 vaccine, check Frequently Asked Questions about COVID-19 Vaccination | CDC.

      Note:  Additional information will be added as it becomes available.